Evasion of Type I Interferon by SARS-CoV-2

Xia, Hongjie, Cao, Zengguo, Xie, Xuping, Zhang, Xianwen, Chen, John Yun-Chung, Wang, Hualei, Menachery, Vineet D., Rajsbaum, Ricardo +1 more·2020·Cell Reports
DOI 10.1016/j.celrep.2020.108234

Cited by (958)

Items 601–700 of 958

  1. The role of cell death pathways in respiratory viral infection and vaccination: two sides of the same coin
    Sun Min Lee, Eui Ho Kim · 2025 · Frontiers in Immunology
  2. Heterogeneous Evolution Among SARS‐CoV‐2 Genes and Variants of Concern
    Luis Daniel González-Vázquez, Paula Iglesias-Rivas, David Ferreiro, Miguel Arenas · 2025 · Journal of Medical Virology
  3. Viral interference of nucleocytoplasmic transport
    Chia‐Yu Chien, George W. Mobbs, Joel R. L. Ehrenkranz, André Hoelz · 2025 · Journal of Biological Chemistry
  4. SARS-CoV-2 and UPS with potentials for therapeutic interventions
    Jannatul Ferdoush, Rizwaan Abdul Kadir, Selin Kaplanoğlu, Morgan Osborn · 2024 · Gene
  5. Interferon-I modulation and natural products: Unraveling mechanisms and therapeutic potential in severe COVID-19
    Yuheng Song, Jiani Lu, Pengcheng Qin, Hongzhuan Chen, Lili Chen · 2024 · Cytokine & Growth Factor Reviews
  6. Advancing respiratory virus diagnostics: integrating the nasal IFN-I score for improved viral detection
    Marine Mommert-Tripon, Delphine Parraud, Cloé Grosbois, Alexandre Gaymard, Valérie Cheynet, Bruno Lina, Guy Oriol, Frederic J. Laurent, Caroline Duprè, Quentin Semanas et al. · 2024 · EBioMedicine
  7. Transcription Kinetics in the Coronavirus Life Cycle
    Katarzyna Grelewska‐Nowotko, Ahmed Eısa Elhag, Tomasz W. Turowski · 2025 · Wiley Interdisciplinary Reviews - RNA
  8. Structural Understanding of SARS-CoV-2 Drug Targets, Active Site Contour Map Analysis and COVID-19 Therapeutics
    Chandrabose Selvaraj, Dhurvas Chandrasekaran Dinesh, Petra Krafčíková, Evžen Bouřa, Murali Aarthy, Muthuraja Arun Pravin, Sanjeev Kumar Singh · 2021 · Current Molecular Pharmacology
  9. Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins
    Nawneet Mishra, Joan Teyra, RuthMabel Boytz, Shane Miersch, Trudy N. Merritt, Lia Cardarelli, Maryna Gorelik, Filip Mihalič, Per Jemth, Robert A. Davey et al. · 2022 · Journal of Molecular Biology
  10. The Railmap of Type I Interferon Induction: Subcellular Network Plan and How Viruses Can Change Tracks
    Laura Weber, Gabrielle Vièyres · 2022 · Cells
  11. Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study
    Jingyu Wang, Henan Dong, Jie Zhao, Tianning Li, Meng Wang, Chunlei Zhou, Hong Mu · 2023 · Frontiers in Microbiology
  12. Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication
    Rezvan Tavakoli, Pooneh Rahimi, Abolfazl Fateh, Mojtaba Hamidi-Fard, Sana Eybpoosh, Golnaz Bahramali, Seyed Amir Sadeghi, Delaram Doroud, Mohammad Reza Aghasadeghi · 2024 · Journal of Infection and Public Health
  13. COVID-19 and immunity: quo vadis?
    Masayuki Miyasaka · 2021 · International Immunology
  14. The COVID-19 Burden or Tryptophan Syndrome: Autoimmunity, Immunoparalysis and Tolerance in a Tumorigenic Environment
    Luiz Gonzaga Francisco de Assis Barros D’Elia Zanella, Galvão Luciana de Lima · 2021 · Journal of Infectious Diseases and Epidemiology
  15. Cellular Deubiquitylating Enzyme: A Regulatory Factor of Antiviral Innate Immunity
    Sijing Long, Yang Li, Wei Dang, Shuyu Xin, Mingjuan Jiang, Wentao Zhang, Jing Li, Yiwei Wang, Senmiao Zhang, Jianhong Lu · 2021 · Frontiers in Microbiology
  16. The Ramp Atlas: facilitating tissue and cell-specific ramp sequence analyses through an intuitive web interface
    Justin B. Miller, Taylor E Meurs, Matthew W. Hodgman, Benjamin Song, Kyle N. Miller, Mark Ebbert, John S. K. Kauwe, Perry G. Ridge · 2022 · NAR Genomics and Bioinformatics
  17. The COVID-19 Cell Signalling Problem: Spike, RAGE, PKC, p38, NFκB & IL-6 Hyper-Expression and the Human Ezrin Peptide, VIP, PKA-CREB Solution
    Rupert Holms · 2022 · Immuno
  18. Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin
    Sk. Sarif Hassan, Vaishnavi Kodakandla, Elrashdy M Moustafa Mohamed Redwan, Kenneth H. Lundstrom, Pabitra Pal Choudhury, Ángel Serrano‐Aroca, Gajendra Kumar Azad, Alaa A. A. Aljabali, Giorgio Palù, Tarek Mohamed Abd El‐Aziz et al. · 2022 · International Journal of Biological Macromolecules
  19. Clinical features and effectiveness of Chinese medicine in patients with COVID-19 from overseas: A retrospective study in Xiamen, China
    Yuxuan Huang, Na-Fen Li, Chenyao Li, Fang-Ping Zheng, Xiangyang Yao, Bao-Hua Lin, Xianzhong Huang, Nengjiang Zhao, Jia-Yong Yang, Qiumin Chen et al. · 2022 · Frontiers in Public Health
  20. T cell maturation is significantly affected by SARS‐CoV ‐2 infection
    Laura Otto Walter, Chandra Chiappin Cardoso, Íris Mattos Santos‐Pirath, Heloísa Zorzi Costa, Rafaela Gartner, Isabel Werle, Eduarda Talita Bramorski Mohr, Júlia Salvan da Rosa, Tainá Larissa Lubschinski, Mariano Felisberto et al. · 2023 · Immunology
  21. Exploring the Impact of Herbal Therapies on COVID-19 and Influenza: Investigating Novel Delivery Mechanisms for Emerging Interventions
    Lucas Fornari Laurindo, Ledyane Taynara Marton, Giulia Minniti, Victória Dogani Rodrigues, Rodrigo Buzinaro Suzuki, Virgínia Maria Cavallari Strozze Catharin, Rakesh Kumar Joshi, Sandra Maria Barbalho · 2023 · Biologics
  22. Variability of Accessory Proteins Rules the SARS-CoV-2 Pathogenicity
    Sk. Sarif Hassan, Pabitra Pal Choudhury, Vladimir Nikolaevich Uversky, Guy W. Dayhoff, Alaa A. A. Aljabali, Bruce D. Uhal, Kenneth H. Lundstrom, Nima Rezaei, Murat Seyran, Damiano Pizzol et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell epitope mapping
    Felix Schreibing, Monica Toft Hannani, Fabio Ticconi, Eleanor Fewings, James Shiniti Nagai, Matthias Begemann, Christoph Kuppe, Ingo Kurth, Jennifer Kranz, Dario Frank et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection
    Zhuo Long Zhou, Xinyi Zhang, Xiaobo Lei, Xiao Xia, Tao Jiao, Ruiyi Ma, Xiaojing Dong, Qi Jiang, Wenjing Wang, Yujin Shi et al. · 2021
  25. Universal features of Nsp1-mediated translational shutdown by coronaviruses
    Schubert, Katharina, Karousis, Evangelos D., Ban, Ivo, Lapointe, Christopher P., Leibundgut, Marc, Bäumlin, Emilie, Kummerant, Eric, Scaiola, Alain, Schönhut, Tanja, Ziegelmüller, Jana et al. · 2023
  26. SARS-CoV-2 accessory proteins ORF3a and ORF6 alter the miRNome of human lung epithelial cells
    Apoorva, Atul Kumar, Sankha Shubhra Chakrabarti, Sunit K. Singh · 2025 · Molecular Biology Reports
  27. SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation
    Diana M. Battaglia, C. Post, Wenbo Yao, Angela R. Wahl, Lisa E. Gralinski, Hongwei Liu, Hong Dang, Victoria J. Madden, Kristen White, Sarah R. Leist et al. · 2025 · Nature Microbiology
  28. hMPV co-infections: Distinct immunopathogenic mechanisms and clinical implications of viral and bacterial pathogenesis
    Syed Sib Tul Hassan Shah, Iqra Naeem, Nabeel Khalid Bhutta, Han Gao, Fatima Noor · 2025 · Folia Microbiologica
  29. Convergent Evolution and Host-Limiting Impacts of SARS-CoV-2 Revealed by Cellular Experiments
    Ting Zhang, Ren‐Rong Tian, Fengyi Li, Xiaolu Tang, Wenbin He, Zhen-Ping Hao, Lin Zhuo, Jian Lü, Xuemei Lu, Yong‐Tang Zheng · 2025 · Molecular Biology and Evolution
  30. Chlamydia trachomatis modulates the expression of JAK-STAT signaling components to attenuate the type II interferon response of epithelial cells
    Francis L. Fontanilla, Joyce A. Ibana, Rey A. Carabeo, Amanda J. Brinkworth · 2024 · mBio
  31. Biological Significance and Therapeutic Promise of Programmed Ribosomal Frameshifting
    Miora Bruna Ramamonjiharisoa, Sen Liu · 2025 · International Journal of Molecular Sciences
  32. M-Motif, a potential non-conventional NLS in YAP/TAZ and other cellular and viral proteins that inhibits classic protein import
    Michael Kofler, Shruthi Venugopal, Gary Gill, Caterina Di Ciano‐Oliveira, András Kapùs · 2025 · iScience
  33. NSP6 regulates calcium overload-induced autophagic cell death and is regulated by KLHL22-mediated ubiquitination
    Xingyu Tao, Yanan Wang, Jiangbo Jin, Huilin Yan, Hui Yang, Xiaorui Wan, Ping Li, Yanghua Xiao, Qi Yu, Lingjiao Liu et al. · 2025 · Journal of Advanced Research
  34. Host Manipulation Mechanisms of SARS-CoV-2
    Steven E. Massey · 2021 · Acta Biotheoretica
  35. Interferon system for COVID-19
    Alexander N. Narovlyansky, Ershov Fi, Sanin Av, Alexander V. Pronin · 2022 · Immunologiya
  36. Geographical distribution of host's specific SARS-CoV-2 mutations in the early phase of the COVID-19 pandemic
    Mohammad Khalid, David P. Murphy, Maryam Shoai, Jonahunnatha Nesson George-William, Yousef Al‐Ebini · 2022 · Gene
  37. Development of novel SARS-CoV-2 viral vectors
    Huan Liu, Dexi Liu · 2023 · Scientific Reports
  38. SARS-CoV-2: An Update on the Biological Interplay with the Human Host
    Giuseppe Lippi, Fabián Sanchis‐Gomar, Camilla Mattiuzzi, Brandon Michael Henry · 2023 · COVID
  39. Lipin‐2 regulates the antiviral and anti‐inflammatory responses to interferon
    Nagore de Pablo, Clara Meana, Javier Martínez‐García, Pablo Martínez‐Vicente, Manuel Albert, Susana Guerra, Ana Angulo, Jesús Balsinde, Marı́a A. Balboa · 2023 · EMBO Reports
  40. Multiscale Molecular Dynamics Simulations of the Homodimer Accessory Protein ORF7b of SARS-CoV-2
    Min-Kang Hsieh, Jeffery B. Klauda · 2023 · The Journal of Physical Chemistry B
  41. Predicting antibody and ACE2 affinity for SARS-CoV-2 BA.2.86 and JN.1 with in silico protein modeling and docking
    Shirish Yasa, Sayal Guirales-Medrano, Denis Jacob Machado, Colby T. Ford, Daniel A. Janies · 2024 · Frontiers in Virology
  42. Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction
    Wan Gi Byun, Minha Lee, Meehyun Ko, Ji Hyae Lee, Sihyeong Yi, JinAh Lee, Seungtaek Kim, Seung Bum Park · 2024 · Angewandte Chemie International Edition
  43. The risk of intrauterine exposure to SARS‐CoV‐2 in female COVID‐19 patients: A comprehensive review
    Guohua Zhu, Lu Liu, Xixi Huang, Da‐Jin Li, Yi Zhun Zhu, Xin Lü, Meirong Du · 2022 · American Journal of Reproductive Immunology
  44. A 336-nucleotide in-frame deletion in ORF7a gene of SARS-CoV-2 identified in genomic surveillance by next-generation sequencing
    Shantelle Lucas, Morris Saffold Jones, Sangita Kothari, Adrian Madlambayan, Christopher Ngo, Carmen Chan, Iryna V. Goraichuk · 2022 · Journal of Clinical Virology
  45. SARS-CoV-2 RNAs are processed into 22-nt vsRNAs in Vero cells
    Yang Liu, Jian Yu Rao, Yingjie Mi, Lan Chen, Lijuan Feng, Qi Li, Jianing Geng, Xianguang Yang, Xiangjiang Zhan, Lili Ren et al. · 2022 · Frontiers in Immunology
  46. Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2
    L. Oleinik, P. Madonov, M. Pykhtina · 2023 · Molecular Biology
  47. Tolerability, pharmacokinetics, and anti-herpetic activity of orally administered BX795
    Tejabhiram Yadavalli, Sudhanshu Kumar Singh, Abhijit A. Date, Deepak Shukla · 2023 · Biomedicine & Pharmacotherapy
  48. Musculoskeletal and neuromuscular dysfunction due to covid-19 infection: A review
    Vivek Chauhan, Akash Pandey, Adrija Rakshit, Gaytri Mahajan, Shamsher S. Kanwar, Vivek Kumar Dhiman, Devendra Singh · 2023 · Vacunas
  49. Safety of High-Dose Vitamin C in Non-Intensive Care Hospitalized Patients with COVID-19: An Open-Label Clinical Study
    Salvatore Corrao, Massimo Raspanti, Federica Agugliaro, Francesco Gervasi, Francesca Di Bernardo, Giuseppe Natoli, Christiano Argano · 2024 · Journal of Clinical Medicine
  50. Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic
    Marc F.D. Baay, Bruno Lina, Arnaud L Fontanet, Arnaud Marchant, Melanie K. Saville, Philippe Sabot, Joris Vandeputte, Pieter Neels · 2020 · Biologicals
  51. The immunology and immunotherapy for COVID-19
    Yixin Liu, Xinsheng Zhou, Xuan Eric Liu, Xiaotao Jiang · 2021 · Expert Reviews in Molecular Medicine
  52. Uncovering the geometry of protein interaction network: The case of SARS-CoV-2 protein interactome
    Paola Lecca · 2023 · AIP conference proceedings
  53. Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2
    Su Jin Lee, Yujin Kim, Dae‐Gyun Ahn · 2022 · Journal of Microbiology and Biotechnology
  54. A multiscale model suggests that a moderately weak inhibition of SARS-CoV-2 replication by type I IFN could accelerate the clearance of the virus
    Anass Bouchnita, Alexey A. Tokarev, Vitaly A Volpert · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice
    Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, Ethan J. Fritch, James A. Levi, Nicole J. Johnson, Frank Scholle, Lakshmanane Premkumar, Brett L. Hurst, Felipe Lee-Montiel et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2
    Rajeev Rudraraju, Matthew J. Gartner, Jessica Anne Neil, Elizabeth S. Stout, Joseph Chen, Elise J. Needham, Michael See, Charley Mackenzie-Kludas, Leo Lee, Mingyang Wang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Purifying selection and adaptive evolution proximate to the zoonosis of SARS-CoV-1 and SARS-CoV-2
    Jeffrey P. Townsend, Stephen J. Gaughran, Hayley B. Hassler, Jeffrey Nicholas Fisk, Mofeed Nagib, Yinfei Wu, Yaning Wang, Zheng Wang, Alison P. Galvani, Alex Dornburg · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Infection-Simulator, Immunostimulatory and Immunomodulatory Effects of Interferons I and III in Biological Systems: A New Era in Vaccinology and Therapeutics Possible?
    Theodor-Nicolae Carp, Michael Metoudi, Vanshika Ojha · 2024 · Preprints.org
  59. SARS-CoV-2 nucleocapsid induces hyperinflammation and vascular leakage through the Toll-like receptor signaling axis in macrophages
    Zhenlan Yao, Pablo A. Alvarez, Carolina Chavez, Yennifer Delgado, Prashant Kaushal, David Austin, David Austin, Qian Li, Yanying Yu, Anne K. Zaiss et al. · 2026 · Science Advances
  60. Unraveled role of TLR7-mediated interferon signaling activation in COVID-19
    Junjian Xue, Xiao-Yin Wang, Pei‐Hui Wang, Bin Qiao, Pengfei Gao, Bin Ren, Shushan Yan · 2025 · Frontiers in Cellular and Infection Microbiology
  61. Crimean-Congo hemorrhagic fever virus NSm protein inhibits the type I interferon signaling by binding to STAT2
    Rokusuke Yoshikawa, Yasuteru Sakurai, Sayako Kondo, Mayuko Kimura, Jiro Yasuda · 2025 · PLoS neglected tropical diseases
  62. Redundant and distinct mechanisms suppress innate immune activation during SARS-CoV-2 infection
    Fuchun Zhou, Sivakumar Periasamy, Nathaniel D. Jackson, Wan Sze Cheng, Rubén Soto-Acosta, Aarti Tripathi, Kritika Kedarinath, Philipp A. Ilinykh, Chengjin Ye, Shailendra Chauhan et al. · 2026 · PLoS Biology
  63. SARS-CoV-2 Amino Acid Mutations Detection in Greek Patients Infected in the First Wave of the Pandemic
    Niki Vassilaki, Konstantinos Papadimitriou, Anastasios Ioannidis, Nikolaos C. Papandreou, Raphaela S. Milona, Vassiliki A. Iconomidou, Stylianos Chatzipanagiotou · 2022 · Microorganisms
  64. Stroke-induced changes to immune function and their relevance to increased risk of severe COVID-19 disease
    Laura J. McCulloch, Isobel C. Mouat, Kieron South, Barry W. McColl, Stuart McRae Allan, Craig J. Smith · 2022 · Discovery Immunology
  65. Safety, Tolerability, Bioavailability, and Biological Activity of Inhaled Interferon-α2b in Healthy Adults: The IN2COVID Phase I Randomized Trial
    Diego Garcia‐Huidobro, Carolina Iturriaga, Guillermo Pérez‐Mateluna, Paula Fajuri, Nicolás Severino, Marcela D. Urzua, Juan Pablo Fraga, Javiera de la Cruz, M. Cecilia Poli, José Antonio Castro-Rodríguez et al. · 2023 · Clinical Drug Investigation
  66. The Protective Efficacy of Single-Dose Nasal Immunization with Cold-Adapted Live-Attenuated MERS-CoV Vaccine against Lethal MERS-CoV Infections in Mice
    Heejeong Seo, Yunyueng Jang, Dongmi Kwak · 2023 · Vaccines
  67. Organoids in COVID-19: can we break the glass ceiling?
    Chiu Wang Chau, Ryohichi Sugimura · 2023 · Journal of Leukocyte Biology
  68. Progressive Evolutionary Dynamics of Gene-Specific ω Led to the Emergence of Novel SARS-CoV-2 Strains Having Super-Infectivity and Virulence with Vaccine Neutralization
    Amit K. Maiti · 2024 · International Journal of Molecular Sciences
  69. Recombination across distant coronavirid species and genera is a rare event with distinct genomic features
    Juan Ángel Patiño-Galindo, Adolfo García‐Sastre, Jens H. Kuhn, Raúl Rabadán, Gustavo F. Palacios · 2024 · Journal of Virology
  70. SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways
    Eryn Lundrigan, Spencer M. Uguccioni, Christine Hum, Nadine Ahmed, John Paul Pezacki · 2025 · Virology
  71. Anti-interferon armamentarium of human coronaviruses
    Oyahida Khatun, Sumandeep Kaur, Shashank Tripathi · 2025 · Cellular and Molecular Life Sciences
  72. Targeting CTP synthetase 1 to restore interferon induction and impede nucleotide synthesis in SARS-CoV-2 infection
    Youliang Rao, Chao Qin, Bianca Espinosa, Tingyu Wang, Shu Feng, Ali Can Savas, Jill E. Henley, Lucio Comai, Chao Zhang, Pinghui Feng et al. · 2025 · mBio
  73. Mucosal implications of oral Jak3-targeted drugs in COVID patients
    Narendra Kumar, Daniel Segovia, Priyam Kumar, Hima Bindu Atti, Soaham Kumar, Jayshree Mishra · 2025 · Molecular Medicine
  74. SARS-CoV-2 ORF7a Protein Impedes Type I Interferon-Activated JAK/STAT Signaling by Interacting with HNRNPA2B1
    Yujie Wen, Chaochao Li, Tian Tang, Chao Luo, Shan Lu, Na Lyu, Yongxi Li, Rong Wang · 2025 · International Journal of Molecular Sciences
  75. Relationship between SARS-COV-2 And autoimmune neurological diseases
    A. I. Vlasenko, O. A. Portik, G. N. Bisaga, M. P. Topuzova, Малько Валерия Алексеевна, P. Sh. Isabekova, Н. В. Скрипченко, Tatiana M. Alekseeva · 2022 · Journal Infectology
  76. Expression characteristics of non-virion protein of Hirame novirhabdovirus and its transfection induced response in hirame natural embryo cells
    Fenghuang Pan, Jiaojiao Gong, Xinbiao Ma, Xiaoqian Tang, Jing Xing, Xiuzhen Sheng, Heng Chi, Wenbin Zhan · 2023 · International Journal of Biological Macromolecules
  77. Integrated interactome and transcriptome analysis reveals key host factors critical for SARS-CoV-2 infection
    Jie Sheng, Lili Li, Xueying Lv, Meiling Gao, Ziyi Chen, Zhuo Long Zhou, Jingfeng Wang, Aiping Wu, Taijiao Jiang · 2023 · Virologica Sinica
  78. Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities
    Shunta Takazawa, Tomohiro Kotaki, Satsuki Nakamura, Chie Aoki Utsubo, Masanori Kameoka · 2023 · Virus Research
  79. N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2
    Christopher M. Weiss, Hongwei Liu, Erin E. Ball, Ashley R. Hoover, Talia S. Wong, Chun Fung Wong, Samuel S.K. Lam, Tomas Hode, Michael Kevin Keel, Richard M. Levenson et al. · 2023 · PLoS ONE
  80. Regulating Select Agent Chimeras: Defining the Problem(s) Through the Lens of SARS-CoV-1/SARS-CoV-2 Chimeric Viruses
    Elizabeth W. Wells, M. T. Parker · 2023 · Health Security
  81. NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity
    Xi Lv, Ran Chen, Taizhen Liang, Haojie Peng, Qiannan Fang, Shiqi Xiao, Sen Liu, Meilin Hu, Fei Yu, Lixue Cao et al. · 2024 · mBio
  82. Upping the ante: enhanced expression of interferon-antagonizing ORF6 and ORF9b proteins by SARS-CoV-2 variants of concern
    Allen Caobi, Mohsan Saeed · 2024 · Current Opinion in Microbiology
  83. Structural biology of SARS-CoV-2 leader protein (nsp1)
    Johannes Kaub, Toyin Akinselure, Lea C. von Soosten, Gianluca Santoni, Andrea Thorn · 2024 · Crystallography Reviews
  84. Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics
    Vaishali Waman, Paul Ashford, Su Datt Lam, Neeladri Sen, Mahnaz Abbasian, Laurel Woodridge, Yonathan Goldtzvik, Nicola Bordin, Jiaxin Wu, Ian Sillitoe et al. · 2024 · Scientific Reports
  85. Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes
    Crawford Currie, Tor Åge Myklebust, Christian Bjerknes, Bomi Framroze · 2024 · International Journal of Molecular Sciences
  86. Interactions of SARS-CoV-2 with Human Target Cells—A Metabolic View
    Wolfgang Eisenreich, Julian Leberfing, Thomas Rudel, Jürgen Heesemann, Werner Goebel · 2024 · International Journal of Molecular Sciences
  87. The SARS‐unique domain (SUD) of SARS‐CoV‐2 nsp3 protein inhibits the antiviral immune responses through the NF‐κB pathway
    Siyi Xie, Zheng Song, Ran Chen, Xu Zhang, Shuangxin Wu, Jingliang Chen, Peiming Huang, Hanxin Liu, Kaixin Yu, Yixin Zhang et al. · 2024 · Journal of Medical Virology
  88. SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner
    Moe Kobayashi, Nene Kobayashi, Kyoka Deguchi, Seira Omori, Takeshi Ichinohe · 2025 · npj Vaccines
  89. Insights into the virologic and immunologic features of SARS-COV-2
    Ceylan Polat, Koray Ergünay · 2021 · World Journal of Clinical Cases
  90. The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?
    Zhihui Wang, Ming Zhou, Zhenfang Fu, Ling Zhao · 2021 · Frontiers in Immunology
  91. RT-PCR cycle threshold value in combination with visual scoring of chest computed tomography at hospital admission predicts outcome in COVID-19
    Edvin Ingberg, Erik Ahlstrand, Per Cajander, Erika Löf, Martin Sundqvist, Matthias Wegener, Mats Lidén, Sara Cajander · 2022 · Scandinavian Journal of Infectious Diseases
  92. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  93. SARS-CoV-2 ORF6 disturbs nucleocytoplasmic trafficking to advance the viral replication
    Yoichi Miyamoto, Yumi Itoh, Tatsuya Suzuki, Tomohisa Tanaka, Yusuke Sakai, Masaru Koido, Chiaki Hata, Caixia Wang, Mayumi Otani, Kohji Moriishi et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  94. A New SARS-CoV-2 Variant Poorly Detected by RT-PCR on Nasopharyngeal Samples, with High Lethality
    Pierre Fillâtre, Marie-José Dufour, Sylvie Behillil, Rémi Vatan, Pascale Reusse, Alice Gabellec, Nicolas Velmans, Catherine Montagne, Sophie Geffroy Du Coudret, Edith Droumaguet et al. · 2021 · SSRN Electronic Journal
  95. Pyronaridine Protects Against SARS-CoV-2 in Mouse
    Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, Andre Schutzer Godoy, G.D. Noske, Aline Minalli Nakamura, Victor Oliveira Gawriljuk, R.S. Fernandes, Natalia Monakhova, Olga Riabova et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Quantification of nuclear transport inhibition by SARS-CoV-2 ORF6 using a broadly applicable live-cell dose-response pipeline
    Tae Yeon Yoo, Timothy John Mitchison · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  97. A scalable pipeline for SARS-CoV-2 replicon construction based on de-novo synthesis
    Ahmet Can Berkyurek, Elian Lee, Omer Weissbrod, Roni Rasnic, Ilaria Falciatori, Siyuan Chen, Yaniv Erlich · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients
    Marcos Javier Ramos-Benítez, Jeffrey R. Strich, Sara Alehashemi, Sydney R. Stein, Andre T. Rastegar, Adriana A. de Jesus, Farzana Bhuyan, Sabrina C. Ramelli, Ashley L. Babyak, Luis Perez Valencia et al. · 2022 · medRxiv
  99. Circular RNAs in the pathogenesis of SARS-CoV-2: potential diagnostic biomarkers and therapeutic targets
    Jiajie Wu, Lele Li, Wei Xu, Xiaoping Xia, Yingping Wu · 2025 · Functional & Integrative Genomics
  100. Impact of SARS-CoV-2 Wuhan and Omicron Variant Proteins on Type I Interferon Response
    Marija Janevska, Evelien Naessens, Bruno Verhasselt · 2025 · Viruses